- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.42 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x DXE: 1,2-DIMETHOXYETHANE(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 9 residues within 4Å:- Chain A: Y.28, M.134, G.135, Y.136, E.141, H.289, W.290
- Ligands: DXE.1, 6D6.9
Ligand excluded by PLIPEDO.4: 4 residues within 4Å:- Chain A: P.283, T.284, E.285, P.286
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: F.27, Y.30, S.32, Q.33
- Chain B: N.346
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: L.287, T.288, H.289, Y.291, Y.351
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain B: Y.24, F.27, Y.28, N.140, E.141
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain B: D.267, W.278, S.280
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain B: P.248, F.249, K.250, S.310, G.311, T.312
Ligand excluded by PLIPEDO.15: 1 residues within 4Å:- Chain B: Q.79
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain C: Q.23, Y.24, F.27, Y.28, E.141, K.345
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain C: F.182, V.206, F.210, Q.298
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain C: K.151, L.154, K.155, P.156, L.235
Ligand excluded by PLIPEDO.20: 1 residues within 4Å:- Chain C: H.55
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain C: D.40, L.287, T.288, H.289, Y.291
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain C: W.278, S.280
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain D: D.267, W.278, S.280, E.285
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain D: L.122, P.123, E.124, Q.125, Y.153
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain D: D.40, L.287, T.288, H.289
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain D: E.246, T.312, V.328
Ligand excluded by PLIP- 1 x PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE(Non-covalent)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.8: 8 residues within 4Å:- Chain A: D.57, S.157, G.158, N.159, L.235, I.271, G.272, S.273
No protein-ligand interaction detected (PLIP)PEG.28: 9 residues within 4Å:- Chain D: Q.23, Y.24, F.27, Y.28, Y.136, N.140, E.141, K.345, F.349
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Q.23
- 4 x 6D6: 5'-{[(3S)-3-amino-3-carboxypropyl](3-aminopropyl)amino}-5'-deoxyadenosine(Non-covalent)
6D6.9: 32 residues within 4Å:- Chain A: F.12, Y.24, F.25, Y.28, Q.34, M.37, M.38, R.43, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, E.141, M.143, S.146, W.290
- Ligands: EDO.3
17 PLIP interactions:17 interactions with chain A- Hydrogen bonds: A:Q.34, A:C.68, A:G.69, A:E.89, A:E.89, A:A.90, A:S.91, A:V.117, A:E.118, A:M.134
- Water bridges: A:R.15, A:G.71, A:E.132
- Salt bridges: A:R.43, A:E.132
- pi-Stacking: A:F.25, A:F.25
6D6.16: 32 residues within 4Å:- Chain B: F.12, R.15, Y.24, F.25, Y.28, Q.34, M.37, R.43, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, E.141, M.143, S.146, H.289, W.290
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:Q.34, B:G.67, B:C.68, B:G.69, B:S.70, B:E.89, B:E.89, B:A.90, B:V.117, B:E.118, B:M.134, B:W.290
- Water bridges: B:R.15, B:G.71, B:L.73, B:E.132
- Salt bridges: B:R.43, B:E.132
- pi-Stacking: B:F.25
6D6.23: 32 residues within 4Å:- Chain C: F.12, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, E.141, M.143, S.146, H.289, W.290
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:E.132
- Hydrogen bonds: C:Q.34, C:C.68, C:E.89, C:E.89, C:A.90, C:S.91, C:V.117, C:E.132, C:S.146
- Water bridges: C:R.15, C:E.132
- Salt bridges: C:R.43
- pi-Stacking: C:F.25
6D6.29: 30 residues within 4Å:- Chain D: F.12, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, E.141, M.143, S.146, W.290
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:Y.28
- Hydrogen bonds: D:Q.34, D:C.68, D:S.70, D:E.89, D:E.89, D:A.90, D:S.91, D:V.117, D:E.118, D:E.132
- Water bridges: D:R.15, D:G.71, D:E.132
- Salt bridges: D:R.43, D:E.132
- pi-Stacking: D:F.25
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0707. To Be Published
- Release Date
- 2017-03-15
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.42 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x DXE: 1,2-DIMETHOXYETHANE(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE(Non-covalent)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x 6D6: 5'-{[(3S)-3-amino-3-carboxypropyl](3-aminopropyl)amino}-5'-deoxyadenosine(Non-covalent)
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0707. To Be Published
- Release Date
- 2017-03-15
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D